Graves Orbitopathy Market Size and Growth Rate::

“The Global Graves Orbitopathy Market is expected to reach US$ 3,156.2 Mn by 2025 owing to growth in R&D for the development of newer drugs”

Graves Orbitopathy Market Growth Drivers and Restraints:

The global Graves’ orbitopathy market is expected to reach US$ 3,156.2 Mn by 2025. Graves’s ophthalmopathy is an autoimmune inflammatory disorder of the orbit and periorbital tissues, characterized by lid lag, upper eyelid retraction, redness (erythema), swelling, conjunctivitis, and bulging eyes. The global graves orbitopathy market is driven by increasing prevalence of Graves’ disease, Hashimoto’s thyroiditis, and euthyroid. Annually, incidence of Graves’ ophthalmopathy is 16/100,000 in women and 3/100,000 in men. Graves’ hyperthyroidism affects 0.2% of pregnant women. About 3-5 % suffers from severe disease with intense pain, and sight-threatening corneal ulceration or compression of the optic nerve. Additionally, smoking of cigarettes raises the occurrence of Graves’ ophthalmopathy to 7.7 fold. Moreover other risk factors which can lead to this disorder include high cholesterol level, diabetes, peripheral vascular disease, etc. which are driving the market growth due to their increasing prevalence. On the other hand the lack of awareness and side effects associated with the drugs can hamper the growth of global Graves’ orbitopathy market.

Browse More Insights of the report @ https://www.precisionbusinessinsights.com/market-reports/global-graves-orbitopathy-market/

Radioactive Iodine Dominate the Global Graves Orbitopathy Market

Based on the drug class, global graves orbitopathy market is segmented into iodine & iodides, ionic inhibitors, radioactive iodine, corticosteroids, thioamides, and beta blockers. Radioactive iodine tends to dominate the global graves orbitopathy market. It is safer than it sounds; it is given as a pill to treat hyperthyroidism. It gradually shrinks the thyroid gland; it is most commonly preferred therapy in to treat
hyperthyroidism in US.

North America Leads the Global Graves Orbitopathy Market

PBI’s global Graves’ orbitopathy market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America dominated the global Graves’ orbitopathy market through 2014-2018 and expected to dominate over 2019-2025 owing to increase in prevalence of diabetes, hypercholesterolemia, and thyroid diseases. Graves’ disease is the most common cause of hyperthyroidism in the United States, annually there are approximately 30 cases per 100,000 persons. Moreover, improved healthcare facilities, advancement in research & development facilities, high disposable incomes, and rising concern are flourishing the Graves’ orbitopathy market in North American region. Europe Graves’ orbitopathy market accounted for a significant share in global Graves’ orbitopathy market due to the rising concerns of the people. As per a research study conducted by PREGO (Presentation of Graves’ Orbitopathy) incidence of Graves’ orbitopathy in Europe was 10-30/10,000 human annually. Furthermore, life style changes accompanies with prevalence of diseases like diabetes are also adding in the growth of the Europe Graves’ orbitopathy market. Asia Pacific Graves’ orbitopathy market is expected to grow at significant rate due to their emerging economies, increase in the prevalence of smoking among the population, rise in thyroid gland disorder, development of healthcare infrastructure, and technological advancements.
Launch of newer treatment therapies, and strategic alliances are the key strategies adopted by market players

Key player’s profiles in the report are GlaxoSmithKline plc (U.K.), Allergan, plc.(Ireland) Abbott Laboratories (U.S.), RLC LABS (U.S.), AbbVie, Inc.( U.S.), Avalon Ventures (US), Mylan N.V.( U.S.), Pfizer, Inc. (U.S.), and Merck & Co.,Inc. (U.S.).

Avail Sample for more information @ https://www.precisionbusinessinsights.com/request-sample?product_id=16143

Detailed Segmentation of Graves Orbitopathy Market:

By Drug Class
• Iodine & Iodides
• Ionic Inhibitors
• Radioactive Iodine
• Corticosteroids
• Thioamides
• Beta Blockers

By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Others

Geography

o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)

About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights